376 related articles for article (PubMed ID: 31512953)
1. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
[No Abstract] [Full Text] [Related]
2. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
[TBL] [Abstract][Full Text] [Related]
3. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
4. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
5. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice?
Kirchheiner J; Fuhr U; Brockmöller J
Nat Rev Drug Discov; 2005 Aug; 4(8):639-47. PubMed ID: 16056390
[TBL] [Abstract][Full Text] [Related]
6. Potential of whole-genome sequencing-based pharmacogenetic profiling.
Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic information in Swiss drug labels - a systematic analysis.
Jeiziner C; Suter K; Wernli U; Barbarino JM; Gong L; Whirl-Carrillo M; Klein TE; Szucs TD; Hersberger KE; Meyer Zu Schwabedissen HE
Pharmacogenomics J; 2021 Aug; 21(4):423-434. PubMed ID: 33070160
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of pharmacology and applications in pharmacogenetics.
Al-Ghoul M; Valdes R
Clin Lab Med; 2008 Dec; 28(4):485-97. PubMed ID: 19059057
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
Suzuki O; Dong OM; Howard RM; Wiltshire T
Pharmacogenomics; 2019 Sep; 20(14):1005-1020. PubMed ID: 31559919
[No Abstract] [Full Text] [Related]
11. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
Verbelen M; Weale ME; Lewis CM
Pharmacogenomics J; 2017 Oct; 17(5):395-402. PubMed ID: 28607506
[TBL] [Abstract][Full Text] [Related]
12. The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Dias MM; Sorich MJ; Rowland A; Wiese MD; McKinnon RA
Pharm Res; 2017 Aug; 34(8):1544-1550. PubMed ID: 28236061
[TBL] [Abstract][Full Text] [Related]
13. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
[TBL] [Abstract][Full Text] [Related]
14. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
15. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
Ji Y; Si Y; McMillin GA; Lyon E
Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
[TBL] [Abstract][Full Text] [Related]
17. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
18. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
Lazaridis KN
Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
[TBL] [Abstract][Full Text] [Related]
19. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
Hess GP; Fonseca E; Scott R; Fagerness J
Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
